Home › Acute Lymphoblastic Leukemia › Tennessee
Acute Lymphoblastic Leukemia clinical trials in Tennessee
23 studies for Acute Lymphoblastic Leukemia are looking for participants at sites in Tennessee.
Cities in Tennessee
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Research Site, Franklin
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Nov 13, 2026 · NCT07109219HPC Offered for PRESERVE Expansion
- Tristar Centennial Medical Center, Nashville
RecruitingObservational study
Ages 12 to 80 · All sexes · Updated Nov 6, 2026 · NCT07145411Feasibility and Acceptability of Remote Saliva Collection
- St. Jude Children's Research Hospital, Memphis
RecruitingObservational studyHealthy volunteers welcome
Ages 8 to 18 · All sexes · Updated Nov 3, 2026 · NCT07884474A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- TriStar Bone Marrow Transplant / Sarah Cannon Transplant & Cellular Therapy, Nashville
RecruitingPhase 2
6 Months · All sexes · Updated Sep 28, 2026 · NCT06514794Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
- St. Jude Children's Research Hospital, Memphis
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT06819475Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1
Up to age 21 · All sexes · Updated Aug 31, 2026 · NCT04881240CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1
Up to age 21 · All sexes · Updated Aug 28, 2026 · NCT07257419The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- East Tennessee Childrens Hospital, Knoxville
- Saint Jude Children's Research Hospital, Memphis
- The Children's Hospital at TriStar Centennial, Nashville
- and 1 more
RecruitingPhase 1/2
Up to age 22 · All sexes · Updated Aug 25, 2026 · NCT04726241A Study of CTD402 in T-ALL/LBL Patients
- Sarah Cannon Research Insitute, Nashville
RecruitingPhase 1/2
Ages 1 and older · All sexes · Updated Aug 19, 2026 · NCT07070219Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
- St. Jude Children's Research Hospital, Memphis
Recruiting
Ages 20 to 50 · All sexes · Updated Aug 14, 2026 · NCT07191119Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
- Vanderbilt University Medical Center, Nashville
RecruitingObservational study
1 Day – 17 Years · All sexes · Updated Aug 14, 2026 · NCT06274788Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 2
Ages 1 to 18 · All sexes · Updated Jul 16, 2026 · NCT06533748Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma
- St. Jude Children's Research Hospital, Memphis
Recruiting
Ages 18 and older · All sexes · Updated Jul 16, 2026 · NCT06747910Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 4
Ages 1 to 18 · All sexes · Updated Jul 14, 2026 · NCT06289673A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- St. Jude Childrens Research Hospital, Memphis
- Vanderbilt University, Nashville
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 4, 2026 · NCT07228741Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1/2
Up to age 21 · All sexes · Updated Jun 3, 2026 · NCT04195347CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1
Up to age 21 · All sexes · Updated May 19, 2026 · NCT06777979CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 2
Up to age 21 · All sexes · Updated Mar 25, 2026 · NCT06847269A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- TriStar Centennial Medical Center, Nashville
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Mar 24, 2026 · NCT04988555CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1
Up to age 21 · All sexes · Updated Jan 23, 2026 · NCT06326463Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 2
Ages 10 to 30 · All sexes · Updated Dec 4, 2025 · NCT05194397Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.